Live symbol workspace

MRNA market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Status Chart ready

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for MRNA skewed bullish (3 of 6 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

34%

▲ 0.8 pts vs previous week

Avg confidence across 18 calls in the last 7 days

What sources say

Bullish 3 articles

Merck, Moderna Stocks Soar After Melanoma Trial Success

Merck, Moderna Melanoma Vaccine Study Succeeds

RocketLab Rises on Space Interest; Moderna Moves on Flu Shot | Stock Movers

Neutral 3 articles

Moderna’s stock doubles on promising cancer-vaccine results

Moderna Just Got FDA Clearance for Flu Vaccine. The Stock Slips.

US Stock Futures Flat After S&P500, Dow End At Record Highs On Strong Earnings, Easing Geopolitical Concerns — PLTR, AZN, CMG, MRNA In Focus

MRNA News Intelligence (13 articles)

AI-curated news influencing MRNA price, sentiment, and trend

Explore All MRNA News with AI Analysis

Economy

4 months, 3 weeks ago

Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know

A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial …

Impact on MRNA: The decline in these stocks, particularly in the healthcare and biotech sectors, …

Shares of Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna plummeted in the afternoon session … High (80%)

View full analysis →

Yahoo Finance 80% confidence